STB-HO functions as an immunomodulator rather than a direct cytotoxic agent, suppressing MCF-7 cells indirectly by polarizing macrophages toward an anti-tumor M1 phenotype and stimulating IFN-γ–secreting NK cells. This evidence concerns the gene HMOX1 and neoplasm.